Abstract
Walsh G, Stogiannos N, Ohene-Botwe B, et al. R-AI-diographers: investigating the perceived impact of artificial intelligence on radiographers’ careers, roles, and professional identity in the UK. Front Digit Health 2025; 7: 1603511. DOI: 10.3389/fdgth.2025.1603511.
A UK-wide cross-sectional study assessing radiographers’ opinions on artificial intelligence and its impact on the role of the radiographer. Optimism is noted; however, there is a requirement for more AI-centric training required.
Ringel MD, Sosa JA, Baloch Z, et al. 2025 American thyroid association management guidelines for adult patients with differentiated thyroid cancer. Thyroid® 2025; 35(8): 841–985. DOI: 10.1177/10507256251363120.
2025 revised evidence-based recommendations for clinical decision-making in the management of differentiated thyroid carcinoma (DTC) reflecting the changes in science and optimising evidence-based clinical care of patients DTC. Some further critical areas of need for additional research are highlighted.
Hills B and Helle K. From principles to proof: how 2025 made AI governance real in health care. AI Precision Oncol 2026; 3(1): 10–13. DOI: 10.1177/2993091X251408040.
Regulation of artificial intelligence (AI) moved from concept to compliance in 2025. This explores the European Union’s AI Act, the United States’ advanced federal guidance and state legislation, the United Kingdom’s expanded regulator-led oversight, and China’s codified labelling and ethics obligations. These developments in AI show the emergence of auditable AI governance frameworks worldwide.
Quaranta M, Maillou K, D’Souza N, et al. Incidental finding of thickened endometrium in postmenopausal women: a survey of endometrial cancer. Cureus 2023; 15(5): e38538. DOI: 10.7759/cureus.38538.
An interesting paper who’s primary objective is to assess the prevalence of endometrial cancer in asymptomatic and symptomatic postmenopausal women referred to a hysteroscopy service for incidental finding of thickened endometrium. The secondary objective was to identify, for the asymptomatic cohort, an acceptable threshold of endometrial thickness (ET) which should trigger endometrial sampling and its related sensitivity and specificity. A threshold of 11 mm for further investigation in asymptomatic postmenopausal women is suggested. This study adds data to the existing body of evidence for the management of asymptomatic postmenopausal women with incidental increased ET.
He F, Sun L-J, Li L, et al. From imaging to management: enhancing the Breast Imaging Reporting and Data System with contrast-enhanced ultrasound for stratification of breast lesions. Asian J Surg. Epub ahead of print 4 February 2026. DOI: 10.1016/j.asjsur.2026.01.153.
Selective vacuum-assisted biopsy (VAB) improves diagnostic accuracy for intermediate breast lesions. The study evaluated the integrating of the Breast Imaging Reporting and Data System (BI-RADS) with contrast-enhanced ultrasound (CEUS) to optimise pre-biopsy VAB selection. CEUS-BI-RADS integration demonstrates potential for tripartite classification of breast lesions before biopsy, offering valuable guidance for optimal biopsy strategy and enhanced clinical management efficiency.
Elsheikh A, Kildegaard C, Pietersen PI, et al. Ultrasound of lung parenchyma – current state and future. Br J Radiol 2026; 99(1178): 195–205. DOI: 10.1093/bjr/tqaf288.
The evidence base supporting the use of thoracic ultrasound to assess the lung parenchyma has significantly expanded with the recent COVID-19 pandemic increasing the scope of lung parenchymal ultrasound, from diagnosis to monitoring of the disease. The most common indication for thoracic ultrasound for lung parenchymal assessment is for screening and diagnostic purposes. Several new studies have, demonstrated a possible large potential for using thoracic lung ultrasound to monitor lung diseases. Deep learning of contrast-enhanced thoracic ultrasound to aid diagnosis is a new developing area. Despite increasing use of thoracic ultrasound in respiratory medicine, a consensus on assessment of competencies, and education is lacking.
Yusuf GT and Sidhu PS. The benefits of contrast-enhanced ultrasound and why we don’t use more contrast-enhanced ultrasound in clinical practice in the United Kingdom. Br J Radiol. Epub ahead of print 3 February 2026. DOI: 10.1093/bjr/tqag025.
Contrast enhanced ultrasound (CEUS) is not a new modality given its presence in imaging since the 1990s. Significant refinement of the technique, has occurred in this timeframe. Multiple practice guidelines have been developed in the international arena led by the European Society and Federation of Ultrasound in Medicine and Biology (EFSUMB). The most widely recognised role of CEUS is in characterising focal liver lesions (FLLs) with a 20-year review of the literature citing hepatic use as the most published indication. Although CEUS evaluation of FLL constitutes the main imaging indication, there are countless off-licence applications existing including renal and testicular lesion characterisation as well as interventional and intracavity.